- Category
- Micro (2023-24)
- Udyam number
- UDYAM-AP-02-0016962

Urantiis Pharmaceuticals Private Limited
About Urantiis Pharmaceuticals Private Limited
Data last updated:
Urantiis Pharmaceuticals Private Limited is a private limited company based in Tirupati, Andhra Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 06 June 2022.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24290AP2022PTC121896.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vanguru Sudhakar Reddy and Vanguru Subhashini.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – 82/1 – 501 Telephone Colony Srinivasapuram Tirupathi Rural II, Tirupati, Andhra Pradesh, India – 517503.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.73 Cr. For the same year it recorded a net profit of ₹8.84 Lakh (net margin 2.4%) and EBITDA of ₹13.28 Lakh (EBITDA margin 3.6%).
As per MCA filings, the company has open charges of ₹2.5 Cr on record.
Urantiis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-02-0016962). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Urantiis Pharmaceuticals
Contact details
Urantiis Pharmaceuticals Private Limited's registered office is in Tirupati, Andhra Pradesh.
- Registered Address2 – 82/1 – 501 Telephone Colony Srinivasapuram Tirupathi Rural II, Tirupati, Andhra Pradesh, India – 517503
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Urantiis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Urantiis Pharmaceuticals Private Limited, buy the company report.
Financials of Urantiis Pharmaceuticals Private Limited
FY 2025 filings availableUrantiis Pharmaceuticals Private Limited reported revenue of ₹3.73 Cr for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹13.28 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹8.84 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.6% | |
| Net Profit Margin | 2.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Urantiis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Urantiis Pharmaceuticals Private Limited
Urantiis Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vanguru Sudhakar Reddy | Director | 06 Jun 2022 | 4 Years 5 Months | Current |
| Vanguru Subhashini | Director | 24 Feb 2025 | 1 Years 8 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jan 2024 | 100857031 | Others | ₹2.5 Cr | Open |
To see the full charge records of Urantiis Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Urantiis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Urantiis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Urantiis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Urantiis Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Rahamthulla Syed ceased to be Director on 01 Mar 2025.
Frequently asked questions
Urantiis Pharmaceuticals is an active private limited company based in Tirupati, Andhra Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 06 June 2022 (4+ years old) and is registered under CIN U24290AP2022PTC121896.
Urantiis Pharmaceuticals has 2 current directors:
- Vanguru Sudhakar Reddy - Director
- Vanguru Subhashini - Director
The latest financial statements of Urantiis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Urantiis Pharmaceuticals is U24290AP2022PTC121896. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Urantiis Pharmaceuticals was incorporated on 06 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Vijayawada.
Rahamthulla Syed ceased to be Director on 01 Mar 2025. Vanguru Subhashini was appointed as Director on 24 Feb 2025. Vanguru Sudhakar Reddy was appointed as Director on 06 Jun 2022.
Yes, Urantiis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-02-0016962).
The registered office of Urantiis Pharmaceuticals is at 2 – 821 – 501 Telephone Colony Srinivasapuram Tirupathi Rural II, Tirupati, Andhra Pradesh, India – 517503.
Urantiis Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Urantiis Pharmaceuticals has open charges of ₹2.5 Cr and no satisfied charges on record as per latest MCA filings.

